Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Exp Neurol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BIMPISIDIS Z, M Oberg C, Maslava N, Cenci MA, et al
    Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease.
    Exp Neurol. 2017 Mar 8. pii: S0014-4886(17)30066.
    PubMed     Text format     Abstract available


    February 2017
  2. MONNOT C, Zhang X, Nikkhou-Aski S, Damberg P, et al
    Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.
    Exp Neurol. 2017 Feb 18. pii: S0014-4886(17)30048.
    PubMed     Text format     Abstract available


    January 2017
  3. FRAU R, Savoia P, Fanni S, Fiorentini C, et al
    The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Exp Neurol. 2017;291:1-7.
    PubMed     Text format     Abstract available


  4. HAO F, Yang C, Chen SS, Wang YY, et al
    Long-Term Protective Effects of AAV9-Mesencephalic Astrocyte-Derived Neurotrophic Factor Gene Transfer in Parkinsonian Rats.
    Exp Neurol. 2017 Jan 25. pii: S0014-4886(17)30016.
    PubMed     Text format     Abstract available


  5. FJODOROVA M, Torres EM, Dunnett SB
    Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats.
    Exp Neurol. 2017 Jan 25. pii: S0014-4886(17)30019.
    PubMed     Text format     Abstract available


    December 2016
  6. BENTEA E, Van Liefferinge J, Verbruggen L, Martens K, et al
    Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc.
    Exp Neurol. 2016 Dec 23. pii: S0014-4886(16)30418.
    PubMed     Text format     Abstract available


    October 2016
  7. BECK MH, Haumesser JK, Kuhn J, Altschuler J, et al
    Short- and long-term dopamine depletion causes enhanced beta oscillations in the cortico-basal ganglia loop of parkinsonian rats.
    Exp Neurol. 2016;286:124-136.
    PubMed     Text format     Abstract available


    September 2016
  8. MULAS G, Espa E, Fenu S, Spiga S, et al
    Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
    Exp Neurol. 2016 Sep 30. pii: S0014-4886(16)30299.
    PubMed     Text format     Abstract available


  9. WU Q, Yang X, Zhang Y, Zhang L, et al
    Chronic mild stress accelerates the progression of Parkinson's disease in A53T alpha-synuclein transgenic mice.
    Exp Neurol. 2016;285.
    PubMed     Text format     Abstract available


    July 2016
  10. GEE LE, Walling I, Ramirez-Zamora A, Shin DS, et al
    Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
    Exp Neurol. 2016;283.
    PubMed     Text format     Abstract available


    June 2016
  11. CONCANNON RM, Okine BN, Finn DP, Dowd E, et al
    Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.
    Exp Neurol. 2016 Jun 14. pii: S0014-4886(16)30179.
    PubMed     Text format     Abstract available


    May 2016
  12. LI M, Zhou M, Wen P, Wang Q, et al
    The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Exp Neurol. 2016 May 6. pii: S0014-4886(16)30122.
    PubMed     Text format     Abstract available


    April 2016
  13. SGROI S, Capper-Loup C, Paganetti P, Kaelin-Lang A, et al
    Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
    Exp Neurol. 2016 Apr 9. pii: S0014-4886(16)30066.
    PubMed     Text format     Abstract available


    March 2016
  14. MURALIDHARAN A, Jensen AL, Connolly A, Hendrix CM, et al
    Physiological changes in the pallidum in a progressive model of Parkinson's disease: Are oscillations enough?
    Exp Neurol. 2016 Mar 2. pii: S0014-4886(16)30046.
    PubMed     Text format     Abstract available


    February 2016
  15. LELOS MJ, Morgan RJ, Kelly CM, Torres EM, et al
    Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.
    Exp Neurol. 2016 Feb 3. pii: S0014-4886(16)30025.
    PubMed     Text format     Abstract available


    December 2015
  16. ANZAK A, Tan H, Pogosyan A, Khan S, et al
    Subcortical evoked activity and motor enhancement in Parkinson's disease.
    Exp Neurol. 2015 Dec 11. pii: S0014-4886(15)30131.
    PubMed     Text format     Abstract available


    November 2015
  17. BENSAID M, Michel PP, Clark SD, Hirsch EC, et al
    Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Exp Neurol. 2015 Nov 10. pii: S0014-4886(15)30118.
    PubMed     Text format     Abstract available


  18. SASAKI T, Liu K, Agari T, Yasuhara T, et al
    Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
    Exp Neurol. 2015 Nov 7. pii: S0014-4886(15)30117.
    PubMed     Text format     Abstract available


    October 2015
  19. HUANG Q, Du X, He X, Yu Q, et al
    JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Exp Neurol. 2015 Oct 26. pii: S0014-4886(15)30111.
    PubMed     Text format     Abstract available


  20. MARTIN CA, Myers KM, Chen A, Martin NT, et al
    Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction.
    Exp Neurol. 2015 Oct 3. pii: S0014-4886(15)30099.
    PubMed     Text format     Abstract available


    August 2015
  21. MOUNSEY RB, Mustafa S, Robinson L, Ross RA, et al
    Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Exp Neurol. 2015 Aug 2. pii: S0014-4886(15)30058.
    PubMed     Text format     Abstract available


    May 2015
  22. YANG X, Zhao H, Shi H, Wang X, et al
    Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Exp Neurol. 2015 May 19. pii: S0014-4886(15)00154.
    PubMed     Text format     Abstract available


  23. SMITH RC, O'Bryan LM, Mitchell PJ, Leung D, et al
    Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.
    Exp Neurol. 2015;267:165-76.
    PubMed     Text format     Abstract available


    April 2015
  24. CONCANNON RM, Okine BN, Finn DP, Dowd E, et al
    Differential upregulation of the cannabinoid CB receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.
    Exp Neurol. 2015 Apr 17. pii: S0014-4886(15)00121.
    PubMed     Text format     Abstract available


    February 2015
  25. SOMAA F, Bye CR, Thompson LH, Parish CL, et al
    Meningeal cells influence midbrain development and the engraftment of dopamine progenitors in Parkinsonian mice.
    Exp Neurol. 2015 Feb 20. pii: S0014-4886(15)00040.
    PubMed     Text format     Abstract available


  26. VANHAUWAERT R, Verstreken P
    Flies with Parkinson's disease.
    Exp Neurol. 2015 Feb 20. pii: S0014-4886(15)00043.
    PubMed     Text format     Abstract available


    November 2014
  27. MANGO D, Bonito-Oliva A, Ledonne A, Cappellacci L, et al
    Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
    Exp Neurol. 2014;261:733-43.
    PubMed     Text format     Abstract available


    October 2014
  28. HADACZEK P, Wu G, Sharma N, Ciesielska A, et al
    GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
    Exp Neurol. 2014;263C:177-189.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: